Stay updated on Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Sign up to get notified when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.0%
    Check dated 2025-02-02T21:58:09.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-19T11:59:12.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The website has updated its contact information for several principal and sub-investigators, including the addition of new contacts and the removal of previous ones, while also noting a revision update from v2.13.3 to v2.14.0.
    Difference
    9%
    Check dated 2025-01-12T06:57:43.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.0%
    Check dated 2024-12-14T12:21:56.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study, along with the location details.
    Difference
    2%
    Check dated 2024-12-07T10:29:40.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Several key URLs related to genetics, lung cancer, and medical resources have been removed, indicating a potential shift in focus or resource availability on the website.
    Difference
    3%
    Check dated 2024-11-23T03:51:34.000Z thumbnail image

Stay in the know with updates to Cabozantib in RET+ NSCLC: Phase II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantib in RET+ NSCLC: Phase II Clinical Trial page.